Patents Assigned to Segev Laboratories Limited
  • Publication number: 20130137755
    Abstract: The present invention relates to a novel delivery system for delivering therapeutic agents into living cells, and more particularly, to novel chemical moieties that are designed capable of targeting and/or penetrating cells or other targets of interest and further capable of binding therapeutic agents to be delivered to these cells, and to delivery systems containing same.
    Type: Application
    Filed: October 22, 2012
    Publication date: May 30, 2013
    Applicant: Segev Laboratories Limited
    Inventor: Segev Laboratories Limited
  • Patent number: 8293209
    Abstract: The present invention relates to a novel delivery system for delivering therapeutic agents into living cells, and more particularly, to novel chemical moieties that are designed capable of targeting and/or penetrating cells or other targets of interest and further capable of binding therapeutic agents to be delivered to these cells, and to delivery systems containing same.
    Type: Grant
    Filed: October 22, 2009
    Date of Patent: October 23, 2012
    Assignee: Segev Laboratories Limited
    Inventor: David Segev
  • Publication number: 20080004234
    Abstract: A novel class of oligomeric compounds designed for forming conjugates with biologically active substances and delivering these substances to a desired bodily target are disclosed. Novel conjugates of these oligomeric compounds and biologically active moieties, pharmaceutical compositions containing such conjugates, and uses thereof as delivery systems for delivering the biologically active substances to a desired target are further disclosed. Processes of preparing the conjugates and the oligomeric compounds and novel intermediates designed for and used in these processes are also disclosed.
    Type: Application
    Filed: June 1, 2007
    Publication date: January 3, 2008
    Applicant: Segev Laboratories Limited
    Inventor: David Segev